AGTC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AGTC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.
Applied Genetic Technologies's adjusted book value per share for the three months ended in Sep. 2022 was $0.261. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Sep. 2022.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.
As of today (2024-05-05), Applied Genetic Technologies's current stock price is $0.3936. Applied Genetic Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2022 was $0.00. Applied Genetic Technologies's Cyclically Adjusted PB Ratio of today is .
The historical data trend for Applied Genetic Technologies's Cyclically Adjusted Book per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied Genetic Technologies Quarterly Data | ||||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
Cyclically Adjusted Book per Share | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Applied Genetic Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Applied Genetic Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Applied Genetic Technologies's Cyclically Adjusted PB Ratio falls into.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.
What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?
Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.
We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
For example, Applied Genetic Technologies's adjusted Book Value per Share data for the three months ended in Sep. 2022 was:
Adj_Book | = | Book Value per Share | / | CPI of Sep. 2022 (Change) | * | Current CPI (Sep. 2022) |
= | 0.261 | / | 125.2265 | * | 125.2265 | |
= | 0.261 |
Current CPI (Sep. 2022) = 125.2265.
Applied Genetic Technologies Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201212 | 0.000 | 96.871 | 0.000 |
201303 | 0.000 | 98.209 | 0.000 |
201306 | -5.255 | 98.518 | -6.680 |
201309 | -3.226 | 98.790 | -4.089 |
201312 | 2.244 | 98.326 | 2.858 |
201403 | -5.080 | 99.695 | -6.381 |
201406 | 5.317 | 100.560 | 6.621 |
201409 | 6.212 | 100.428 | 7.746 |
201412 | 5.970 | 99.070 | 7.546 |
201503 | 5.632 | 99.621 | 7.080 |
201506 | 5.191 | 100.684 | 6.456 |
201509 | 5.416 | 100.392 | 6.756 |
201512 | 5.658 | 99.792 | 7.100 |
201603 | 5.829 | 100.470 | 7.265 |
201606 | 6.055 | 101.688 | 7.457 |
201609 | 6.334 | 101.861 | 7.787 |
201612 | 6.525 | 101.863 | 8.022 |
201703 | 6.548 | 102.862 | 7.972 |
201706 | 6.376 | 103.349 | 7.726 |
201709 | 6.378 | 104.136 | 7.670 |
201712 | 6.163 | 104.011 | 7.420 |
201803 | 5.779 | 105.290 | 6.873 |
201806 | 5.472 | 106.317 | 6.445 |
201809 | 4.354 | 106.507 | 5.119 |
201812 | 4.183 | 105.998 | 4.942 |
201903 | 4.860 | 107.251 | 5.675 |
201906 | 4.323 | 108.070 | 5.009 |
201909 | 3.731 | 108.329 | 4.313 |
201912 | 3.295 | 108.420 | 3.806 |
202003 | 3.292 | 108.902 | 3.785 |
202006 | 2.753 | 108.767 | 3.170 |
202009 | 2.173 | 109.815 | 2.478 |
202012 | 1.603 | 109.897 | 1.827 |
202103 | 2.269 | 111.754 | 2.543 |
202106 | 2.005 | 114.631 | 2.190 |
202109 | 1.622 | 115.734 | 1.755 |
202112 | 1.200 | 117.630 | 1.278 |
202203 | 0.927 | 121.301 | 0.957 |
202206 | 0.578 | 125.017 | 0.579 |
202209 | 0.261 | 125.227 | 0.261 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.
For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.
Thank you for viewing the detailed overview of Applied Genetic Technologies's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Susan Schneider | officer: Chief Medical Officer | C/O APPLIED GENETIC TECHNOLOGIES CORP., 14193 NW 119TH TERRACE, SUITE 10, ALACHUA FL 32615 |
Jonathan I Lieber | officer: Chief Financial Officer | C/O HISTOGENICS CORPORATION, 830 WINTER STREET #3, WALTHAM MA 02451 |
Stephen W Potter | officer: See Remarks | 7015 ALBERT EINSTEIN DR, COLUMBIA MD 21046 |
Gerald Anthony Reynolds | officer: Chief Accounting Officer | C/O APPLIED GENETIC TECHNOLOGIES CORP., 14193 NW 119TH TERRACE, SUITE 10, ALACHUA FL 32615 |
Susan B. Washer | director, officer: President and CEO | C/O APPLIED GENETIC TECHNOLOGIES CORP., 11801 RESEARCH DRIVE, SUITE D, ALACHUA FL 32615 |
Hope Doyley-gay | officer: General Counsel | C/O APPLIED GENETIC TECHNOLOGIES CORP., 14193 NW 119TH TERRACE, SUITE 10, ALACHUA FL 32615 |
Abraham Scaria | officer: Chief Scientific Officer | C/O APPLIED GENETIC TECHNOLOGIES CORP, 14193 NW 119TH TERRACE, SUITE 10, ALACHUA FL 32615 |
Yehia Hashad | director | C/O APPLIED GENETIC TECHNOLOGIES CORP., 14193 NW 119TH TERRACE, SUITE 10, ALACHUA FL 32615 |
Robinson James A. Jr. | director | 852 WINTER STREET, WALTHAM MA 02451 |
William Aliski | director | C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO CA 94949 |
Krol Patrick Johan Hendrik | 10 percent owner | GUSTAV MAHLERPLEIN 3, AMSTERDAM P7 1082 MS |
Privium Fund Management B.v. | 10 percent owner | GUSTAV MAHLERPLEIN 3, AMSTERDAM P7 1082 MS |
Aescap 2.0 Stichting | 10 percent owner | GUSTAV MAHLERPLEIN 3, AMSTERDAM P7 1082 MS |
Inspirational Visions B.v. | 10 percent owner | C/O PROQR THERAPEUTICS N.V., ZERNIKEDREEF 9, 2333 CK LEIDEN P7 2333 |
Brian Krex | officer: General Counsel | C/O AGTC, 14193 NW 119TH TERRACE, SUITE #10, ALACHUA FL 32615 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-09-2022
By PurpleRose PurpleRose • 07-12-2022
By PRNewswire PRNewswire • 10-24-2022
By GuruFocusNews GuruFocusNews • 07-07-2022
By Business Wire Business Wire • 10-26-2022
By GlobeNewswire GlobeNewswire • 10-24-2022
By Value_Insider Value_Insider • 11-28-2022
By GuruFocusNews GuruFocusNews • 07-06-2022
By Value_Insider Value_Insider • 11-22-2022